Target

BTK (Bruton's tyrosine kinase)

Aliases

BTK

9 products, 5 indications

Indications

non-hodgkin lymphoma (4 products)

Chronic Lymphocytic Leukemia (4 products)

NSCLC (1 products)

Double expression (DE) DLBCL (1 products)

glioblastoma (1 products)

5 drugs

1 abstract

Abstract

Phase I clinical study of orally-dosed HBW-3220 in patients with relapsed/refractory B-cell lymphoma.

Org: Chengdu Hyperway Pharmaceuticals, Chengdu Hyperway Pharmaceuticals, Chengdu, Sichuan, China, Chengdu Hyperway Pharmaceuticals, Chengdu, Sichuan., China,

Drug

Drug

Drug

Drug

Drug